Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2

NCT03867435 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT03867435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03867435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Observational
Overall status
Terminated
Start date
February 24, 2020
Completion date
November 2, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myotonic dystrophy type-1, myotonic dystrophy type-2